Dana Farber Cancer Institute Clinical Research Coordinator

Boston, Massachusetts 02115

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma

Studies at this site

• Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants — Completed
• Safety Study of LBH589 When Given in Combination With Bortezomib in Adult Patients With Multiple Myeloma — Completed